至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Rocaglates as dual-targeting agents for experimental cerebral malaria.

Proc. Natl. Acad. Sci. U.S.A.. 2018; 
LanglaisDavid,CencicRegina,MoradinNeda,KennedyJames M,AyiKodjo,BrownLauren E,CrandallIan,TarryMichael J,SchmeingMartin,KainKevin C,PorcoJohn A,PelletierJerry,GrosPhil
Products/Services Used Details Operation
Codon Optimization y. A codon-optimized variant of PfeIF4A (XM_001348793.1) for increased bacterial expression was synthesized by Genscript and cloned into pET15b utilizing NdeI and BamHI restriction sites. Get A Quote
Bacterial Expression System Get A Quote

摘要

Cerebral malaria (CM) is a severe and rapidly progressing complication of infection by parasites that is associated with high rates of mortality and morbidity. Treatment options are currently few, and intervention with artemisinin (Art) has limited efficacy, a problem that is compounded by the emergence of resistance to Art in parasites. Rocaglates are a class of natural products derived from plants of the genus that have been shown to interfere with eukaryotic initiation factor 4A (eIF4A), ultimately blocking initiation of protein synthesis. Here, we show that the rocaglate CR-1-31B perturbs association of eIF4A (PfeIF4A) with RNA. CR-1-31B shows potent prophylactic and therapeutic antiplasmodial a... More

关键词

Plasmodium,cerebral malaria,dual target,protein translation,severe mal